Recordati S.p.A.
$58.00▲ 0.00%(+$0.00)
TickerSpark Score
71/100
▌ Solid
73
Valuation
90
Profitability
70
Growth
72
Health
50
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RCDTF research report →
52-Week Range22% of range
Low
$55.88
Current
$58.00
High
$65.44
Company Overviewwww.ricoh.com
About the company
Recordati Industria Chimica e Farmaceutica S. p. A.
- CEO
- Robert Koremans
- IPO
- 2010
- Employees
- 4,614
- HQ
- Milan, MI, IT
Price Chart
-11.37% · this period
Valuation
- Market Cap
- $11.80B
- P/E
- 22.33
- P/S
- 3.94
- P/B
- 5.09
- EV/EBITDA
- 13.38
- Div Yield
- 2.61%
Profitability
- Gross Margin
- 69.38%
- Op Margin
- 28.50%
- Net Margin
- 17.79%
- ROE
- 24.25%
- ROIC
- 12.62%
Growth & Income
- Revenue
- $2.62B · 11.82%
- Net Income
- $443.62M · 6.51%
- EPS
- $2.15 · 6.44%
- Op Income
- $719.74M
- FCF YoY
- 281.97%
Performance & Tape
- 52W High
- $65.44
- 52W Low
- $55.88
- 50D MA
- $57.86
- 200D MA
- $61.81
- Beta
- 0.54
- Avg Volume
- 14
Get TickerSpark's AI analysis on RCDTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · RCDTF
Our RCDTF coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on RCDTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RCDTF report →Internal Compare
Similar companies
Peers in the same neighborhood.
CSPCY▲8.17%
CSPC Pharmaceutical Group Limited
$3.84
GIFLF▲0.38%
Grifols, S.A.
$10.49
SFOSF▲0.00%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
$2.02
ORINF▲0.00%
Orion Oyj
$82.75
BDULF▲0.00%
Bangkok Dusit Medical Services Public Company Limited
$0.56
GIFOF▲0.00%
Grifols, S.A.
$8.85
CHJTF▲0.00%
CSPC Pharmaceutical Group Limited
$0.98
BIOVF▲0.00%
Swedish Orphan Biovitrum AB (publ)
$48.00